| 1 |
35151910 | BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma. | 2022 May |
1 |
| 2 |
32124385 | Somatic mRNA Analysis of BRCA1 Splice Variants Provides a Direct Theranostic Impact on PARP Inhibitors. | 2020 Apr |
1 |
| 3 |
32856862 | Recurrent BRCA1 Mutation, but no BRCA2 Mutation, in Vietnamese Patients with Ovarian Carcinoma Detected with Next Generation Sequencing. | 2020 Aug 1 |
1 |
| 4 |
32876438 | Potential Doxorubicin-Mediated Dual-Targeting Chemotherapy in FANC/BRCA-Deficient Tumors via Modulation of Cellular Formaldehyde Concentration. | 2020 Oct 19 |
1 |
| 5 |
32903564 | Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection. | 2020 |
1 |
| 6 |
31556562 | Somatic mutations in BRCA1&2 in 201 unselected ovarian carcinoma samples - single institution study. | 2019 |
1 |
| 7 |
31570282 | BRCA1/2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients. | 2019 Nov |
2 |
| 8 |
31653094 | Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy. | 2019 Oct 24 |
1 |
| 9 |
31890056 | Acid-specific formaldehyde donor is a potential, dual targeting cancer chemotherapeutic/chemo preventive drug for FANC/BRCA-mutant cancer. | 2019 |
2 |
| 10 |
29453630 | Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features. | 2018 May |
1 |
| 11 |
29936257 | Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue. | 2018 Sep |
1 |
| 12 |
27767231 | Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas. | 2017 Feb |
1 |
| 13 |
28376189 | Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women. | 2017 Aug 1 |
1 |
| 14 |
27003155 | NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial. | 2016 Jun |
1 |
| 15 |
27514839 | New challenges for BRCA testing: a view from the diagnostic laboratory. | 2016 Sep |
1 |
| 16 |
27533253 | Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples. | 2016 Sep 20 |
1 |
| 17 |
27907908 | Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer. | 2016 Dec 20 |
1 |
| 18 |
24917463 | MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors. | 2015 Feb 1 |
1 |
| 19 |
21839586 | A common environmental carcinogen unduly affects carriers of cancer mutations: carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogen. | 2011 Nov |
3 |
| 20 |
19959799 | Detection of BRCA1 and BRCA2 Ashkenazi Jewish founder mutations in formalin-fixed paraffin-embedded tissues using conventional PCR and heteroduplex/amplicon size differences. | 2010 Jan |
1 |
| 21 |
20041308 | Identification of the first case of germline duplication of BRCA1 exon 13 in an Italian family. | 2010 Sep |
1 |
| 22 |
20834076 | Immunohistochemical expression of BRCA1 protein in invasive ductal carcinoma of the breast. | 2010 Jul-Aug |
1 |
| 23 |
17164758 | The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions. | 2007 Jan 15 |
1 |
| 24 |
18056434 | Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. | 2007 Dec 1 |
2 |